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PURPOSE. Synthesis of keratan sulfate (KS) relies on coordinated action of multiple enzymes,
including the N-acetylglucosamine–transferring enzyme, b-1,3-N-acetylglucosaminyltransfer-
ase-7 (b3GnT7). A mouse model deficient in b3GnT7 was developed to explore structural
changes in KS and the extracellular matrix (ECM; i.e., the corneal stroma), elucidate the KS
biosynthesis mechanism, and understand its role in corneal organization.
METHODS. A knockout vector for the b3GnT7-encoding gene, B3gnt7, was created to develop
heterozygous- (htz) and homozygous-null (null) knockouts. Epithelial, stromal, and whole
cornea thicknesses were measured from each group. Proteoglycans were stained with
cupromeronic blue for visualization by electron microscopy, and Western blot analyses were
conducted on the KS core protein, lumican. Corneal sections were labelled fluorescently for
KS and chondroitin sulfate/dermatan sulfate (CS/DS) using monoclonal antibodies 1B4 or 2B6,
respectively.
RESULTS. Wild-type (WT) and htz corneas were of similar stromal thickness, whereas null
specimens measured relatively thin. Electron micrographs revealed that WT and htz samples
contained comparable levels of KS- and CS/DS-PGs. Null corneas, however, lacked detectable
KS and featured uncharacteristically elongated electron dense PG filaments, which were
susceptible to chondroitinase ABC digestion. Western blotting revealed lumican in the null
corneas was substituted with low-molecular-weight KS, relative to WT or htz tissue. KS was
not immunohistochemically detectable in the null cornea, whereas CS/DS content appeared
increased.
CONCLUSIONS. Addition of N-acetylglucosamine via b3GnT7 to KS glycosaminoglycans is
necessary for their biosynthesis. Without b3GnT7, murine corneal stromas lack KS and
appear to compensate for this loss with upregulation of chondroitinase ABC-sensitive PGs.
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sulfotransferase
Keratan sulfate (KS) is an extracellular matrix (ECM)glycosaminoglycan (GAG) present in a host of tissues in
many organisms spanning the animal kingdom. Its exact
structure varies depending on the organism and tissue in
which it is found (see Funderburgh 20021 for comprehensive
review). The highest abundance of KS in the body is found in
the cornea, where KS-GAGs covalently associate to core
proteins lumican, keratocan, or mimecan via an N-linkage to
asparagine (Asn) residues, thus forming a proteoglycan (PG).
KS-GAGs are also commonly found in cartilage and brain, where
their association to core proteins occurs via an O-linkage to
serine (Ser) or threonine (Thr) residues.
The linkage region of corneal KS-GAGs is comprised of two
N-acetylglucosamine (GlcNAc) residues, the innermost of
which is fucosylated at its sixth carbon (C6).1,2 Three mannose
residues divide the molecule into its bi-antennary structure,
from which its short and long arms extend (shown in Fig. 1).
Both short and long arms contain GlcNAc and galactose
residues linked in –3Galb1,4GlcNAcb1– conformation, also
known as poly-N-acetyllactosamine.3 The long arm of KS
contains three regions of repeating disaccharides, distinguished
by their degree of sulfation. The unsulfated region does not
contain sulfate modification on GlcNAc or galactose and is one
to two disaccharides long. The monosulfated region, however,
is 10 to 12 disaccharides in length and carries sulfate groups at
the C6 of GlcNAc residues. Sulfate moieties bind GlcNAc and,
less frequently, galactose within the disulfated region of corneal
KS-GAGs. The disulfated region varies in length and often
terminates with a sialic acid capping structure.2,4 The short arm
of KS-GAGs lacks the mono- and disulfated regions described
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above and instead terminates with sialic acid following one to
two unsulfated disaccharide repeats.5 The frequent substitu-
tion of sulfate groups along their carbohydrate backbones
confers upon KS-GAGs their dense negative charge, and, in
turn, their hydrophilicity.
Importantly, the sulfation status of KS can impact on tissue
function; a prime example is where a disturbed KS sulfation
pathway leads to progressive loss of vision as in the inherited
disease macular corneal dystrophy.6–10 The causative gene is
CHST6, which encodes corneal GlcNAc 6-O-sulfotransferase
(CGn6ST).11,12 Consequences of the abnormally sulfated PG
population include altered collagen architecture within the
cornea and stromal opacifications, which can only be treated
by a corneal graft. Structural matrix changes mimicking those
seen in human corneas with macular corneal dystrophy have
also been documented in mouse corneas lacking Chst5, which
is the murine orthologue of the human CGn6ST-encoding
gene.13–15
The apparent importance for properly formed KS has
sparked recent interest in elucidating the biosynthetic mech-
anism that elongates and sulfates KS-GAGs. It is thought that at
least four enzymes, including two glycosyltransferases and two
sulfotransferases, are required for KS biosynthesis. A number of
studies have posited that highly sulfated KS-GAGs are formed
by addition of GlcNAc via b-1,3-N-acetylglucosaminyltransfer-
ase 7 (b3GnT7, encoded by B3gnt7) to the nonreducing
terminus of the growing KS chain.16 It is thought that CGn6ST
(described above) subsequently sulfates the 6-O position of
GlcNAc prior to galactose addition by b-1,4-galactosyltransfer-
ase 4 (b4GalT4, encoded by B4galt4). It is hypothesized that
these three steps repeat, forming a chain of disaccharides
singly sulfated on GlcNAc residues.17,18 It has been suggested
that galactose sulfation is achieved in a separate step, since the
discovery that KS galactose 6-O-sulfotransferase (KSGal6ST,
encoded by Chst1) preferentially sulfates internal, rather than
terminal, galactose residues.19,20
The work herein furthers our understanding of corneal KS
biosynthesis, specifically investigating the role of the glycosyl-
transferase b-1,3-N-acetyltransferase 7 (b3GnT7). Whereas
previous work has demonstrated the GlcNAc-transferring
capability of b3GnT7 in vitro, we generated a B3gnt7-null
mouse and explored the consequences of this mutation in the
cornea. Our results suggest that without the ability to elongate
KS chains via addition of GlcNAc residues at their non-reducing
termini, the normal corneal stromal KS-PG phenotype is
abolished.
METHODS
Knockout Mouse Production
Knockout vector for B3gnt7 was prepared by recombineering
technique.21 Bacterial artificial chromosome (BAC) clones
(RP24-231G17 and RP24_144F16), which included B3gnt7,
were obtained from BACPAC resources (Children’s Hospital
Oakland Research Institute, Oakland, CA, USA). Because most
of the protein coding sequence is encoded on exon 2 of the
gene, the loxP sequence was inserted before and after exon 2.
A neo cassette, which consists of flippase recombinase target
(FRT)-phosphoglycerate kinase promoter (PGK)-neomycin
resistant gene (neo)-FRT was also inserted downstream of
exon 2. The DNA fragment containing modified B3gnt7 was
retrieved to pBSII-DTA vector and used as a knockout vector.
This vector was introduced into RENKA mouse embryonic
stem (ES) cells, which were derived from C57BL/6 strain22 by
electroporation. Resultant homologous recombinant clones
were isolated after G418 selection. Homologous recombination
occurred on the ES clones and was confirmed by Southern blot
analysis. The confirmed ES cells were then used to create
chimeric mice carrying ES-derived germ cells. The chimeric
mice were mated with C57BL/6J mice to obtain B3gnt7
heterozygous mice, and the heterozygote mice were inter-
crossed to produce wild-type (WT; B3gnt7þ/þ), heterozygous
(þ/), and null (/) mice. B3gnt7 heterozygous mice were also
mated to C57BL/6J mice to maintain the strain. All procedures
were approved by the Committee for Animal Experiments at
Kansai Medical University, conducted according to the
Guideline for Animal Experimentation at Kansai Medical
University, and treated in accordance with the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research.
Corneal Thickness Assay
Excised eyes of 32 mice (12- to 16-week-old mice of both
sexes, 5 WT, 10 htz, and 17 null) were embedded in Tissue-Tek
OCT compound (Sakura Finetek, Tokyo, Japan) and immedi-
ately frozen by dry ice. Axial whole eye sections (4 lm) were
taken using Kawamoto’s film method.23 It was inferred that the
sections were central and suitable for analysis when pupil
FIGURE 1. Structure of corneal KS-GAGs. Asparagine residues (ASN) within KS-PG core proteins (black) are bound via an N-linkage to two
GlcNAc residues (light blue), followed by three mannose residues (orange), which divide the molecule into two arms. The innermost linkage
GlcNAc is fucosylated at C6. The elongated (top) and short (bottom) arms both contain repeating GlcNAc and galactose (green) residues linked
in –3Galb1,4GlcNAcb1– repeating fashion. Whereas these inner disaccharide repeats do not carry sulfate modification, GlcNAc residues in the
monosulfated region of the molecule are sulfated at C6. The C6 positions of GlcNAc and most, but not all, galactose residues are modified by
sulfate in the disulfated region of KS-GAGs.
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diameter was at its maximum and the optic nerve was present
in the section. Unstained central corneal sections were then
directly observed using phase-contrast mode of an All-in-One
Microscope BZ-9000 (Keyence, Osaka, Japan). Thickness of the
central cornea, stroma, and epithelium was analyzed using a
measurement module of the microscope, which quantifies
distance between two parallel lines. A mean value of each
section was calculated from three measurements per section.
Statistical analysis of thicknesses was performed by 1-way
ANOVA with Dunnett’s post hoc test. P < 0.03 compared with
WT was considered significant.
Western Blot
Protein Extraction. Ten corneas from each group were
minced manually using a scalpel and placed in extraction
solution containing 4 M guanidine hydrochloride (Gu-HCl); 50
mM Tris/hydrochloride (Tris/HCl), pH 8.0; 10 mM EDTA; 1 mM
PMSF; and 13 protease inhibitor cocktail (Nacalai Tesque,
Kyoto, Japan). The protease inhibitor cocktail was diluted from
a 1003 stock, comprised of 50 mmol/L 4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride (AEBSF), 15 lmol/L
aprotinin, 100 lmol/L E-64, and 100 lmol/L leupeptin hemi-
sulfate monohydrate. Corneal tissue was physically pulverized
using a benchtop homogenizer (Polytron 1600 E with PT-DA
1605 blade; Kinematica AG, Luzern, Switzerland) and then
incubated 48 hours with rotation at 48C in extraction solution
(above). Following extraction, samples were centrifuged to
separate debris in the pellet from extracted protein in the
supernatant solution; the supernatant was then dialyzed in 1 L
6 M urea with 50 mM Tris/HCl (pH 8.0). The dialysis solution
was refreshed at 4 hours of incubation, after which dialysis was
continued overnight at 48C with agitation. Resultant protein
solutions were again centrifuged to remove debris and then
concentrated by centrifugation in centrifugal filter units
(Amicon Ultra-4, pore size: 30 kDa; Merck Millipore, Cork,
Ireland) at 48C and 2330g. Protein concentration of each
extract was determined using the Pierce BCA Protein Assay kit
(Pierce Biotechnology, Rockford, IL, USA) after dilution of the
sample solutions with water to minimize interference of urea.
Bovine serum albumin (BSA) was used to set a standard curve.
All samples were measured in duplicate.
PNGase F Digestion. Peptide-N-glycosidase F (PNGase F)
was used to determine whether the production of lumican
core protein was affected in the heterozygous and homozygous
B3gnt7-null mice. PNGase F cleaves KS-GAGs at the linkage
GlcNAc residue, separating KS-GAGs from their lumican
protein cores. Protein extracts from WT, htz, and null corneas
were precipitated using a 4:1 ratio of methanol/chloroform24
as follows. A volume of corneal extract equal to 30 lg protein
was brought to 100 lL using distilled water. Ice cold methanol
(400 lL) was added to the protein sample; the mixture was
vortexed briefly and centrifuged to collect the solution in the
base of the tube. Chloroform (100 lL) was then added to the
protein/methanol mixture; the new solution was again
vortexed briefly and collected into the base of the tube via
centrifugation. Distilled water (300 lL) was subsequently
added to the protein/methanol/chloroform mixture, vortexed
thoroughly (~30 seconds), and centrifuged for 2 minutes at
20,000g. Following centrifugation, a protein wafer appeared at
the interface of the upper aqueous and lower organic layers.
After removal of the upper aqueous layer, an additional 300 lL
ice-cold methanol was added to the protein sample. Thorough
vortexing was conducted for ~10 seconds, and the new
mixture was subjected to 20,000g centrifugation. The protein
pellet appeared at the base of the tube, so the supernatant was
removed, and the pellet was allowed to air dry before
resuspending in 20 lL 1% SDS. Protein contents were
measured again using the Pierce BCA Protein Assay Kit before
PNGase-F digestion. PNGase-F treatment was performed by
following the protocol of the company (New England Biolabs,
Ipswich, MA, USA). In brief, a volume equaling 5 lg
resuspended protein was denatured at 1008C for 10 minutes
in manufacturer-provided glycoprotein denaturing buffer.
Manufacturer-provided reaction buffer and NP-40 solution,
which allows PNGase F activity in the presence of SDS, were
added to denatured samples. Digestion was achieved by
addition of 1 lL PNGase F (100 U/lg protein) at 378C
overnight. Digested samples were directly analyzed using
SDS-PAGE and Western blot.
Endo-b-Galactosidase Digestion. To gain insight into the
KS structure of htz and null corneas, endo-b-gal-ase was used.
Five micrograms corneal extract was precipitated from the
extraction solution (see Protein Extraction section) with
methanol/chloroform as described in the PNGase F Digestion
section and resuspended in 1% SDS. Resuspended solution was
diluted and adjusted to 100 lL 50 mM sodium acetate, pH 6.5,
0.1% Triton X-100, and 13 proteinase inhibitor cocktail. Then,
0.5 milliunits of endo-b-gal-ase was added (0.1 mU/lg protein)
and allowed to incubate overnight at 378C with rotation. The
protein samples were subsequently precipitated with metha-
nol/chloroform as described above and were resuspended in
electrophoresis sample buffer, described in the next section.
Electrophoresis. Five micrograms protein was prepared
for Western blotting from untreated, PNGase F- and endo-b-gal-
ase–digested samples. Samples were adjusted to 60 lL
containing 13 NuPAGE LDS sample buffer and 13 reducing
agent (Thermo Fisher Scientific, Rockford, IL, USA) and were
denatured by boiling and then loaded into a 4% to 12% Bis-Tris
polyacrylamide gel (Thermo Fisher Scientific). Constant
voltage (200 V) was applied for 45 minutes or until samples
reached the bottom of the gel. Immediately after electropho-
resis, protein samples within the acrylamide gel were
transferred to a PVDF membrane by electroblotting at 30 V
for 1 hour. Blocking the protein-laden membrane was achieved
at room temperature using 5% skimmed milk for 1.5 hours.
Goat polyclonal anti-lumican primary antibody (R&D Systems,
Minneapolis, MN, USA) was diluted 1:1000 in 5% skimmed milk
and applied to the membrane for 1 hour. PBS with 0.1% Tween-
20 (PBS-T) was used to rinse excess antibody from the
membrane (33, 5 minutes each). Horseradish peroxidase–
conjugated secondary antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), which recognized goat IgG, was diluted
1:2000 in 5% skimmed milk and applied to the membrane
surface for 1 hour. To develop the membranes, Chemi-Lumi
One chemiluminescence substrate (Nacalai Tesque) was
applied to the membrane for 2 minutes. Chemiluminescent
images were captured using LAS 3000 Mini camera and
software (Fuji Photo Film, Tokyo, Japan) using 1 to 10 minutes
of exposure, depending on the amount of signal produced by
the membrane.
Electron Microscopy
Whole corneas from WT, htz, and null mice were excised and
immediately prefixed in 4% paraformaldehyde in 0.1 M
Sorensen phosphate buffer (pH: 7.4) for 10 minutes. After
initial fixation, excess prefixative was rinsed with 13 Tris-
acetate buffer, and whole corneas were further dissected into
quarters. ‘‘Untreated’’ (i.e., not subjected to chondroitinase
ABC or buffer reaction conditions) corneal quarters were
immediately placed into 2.5% (w/v) glutaraldehyde (Agar
Scientific Ltd., Stansted, United Kingdom) in 25 mM sodium
acetate buffer (pH 5.7) with 0.05% cupromeronic blue (w/v)
(Sigma, St. Louis, MO, USA) and magnesium chloride (MgCl2) at
critical electrolyte concentration, 0.1 M—a concentration
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known to enhance PG staining.25,26 To allow for KS
visualization, remaining corneal quarters from each genotype
were digested with chondroitinase ABC for 4 hours at 378C in
the following reaction mixture: 1 lg/mL chondroitinase ABC
was added to 13 Tris-acetate buffer þ bovine serum albumin
(pH 8), including 10 ll/mL general protease inhibitor. Samples
were subjected to constant agitation for the duration of the
reaction. Following incubation, specimens were rinsed in 25
mM sodium acetate buffer containing 0.1 M MgCl2 and further
fixed/stained overnight at room temperature on a rotator in the
cupromeronic blue solution described above. One corneal
quarter from each group was also processed in buffer solution
lacking chondroitinase ABC as a control. Fixed and stained
specimens (untreated, chondroitinase ABC digested, and buffer
treated) were washed three times (10 min/wash) in 0.5% (w/v)
sodium tungstate (Sigma) and then dehydrated using an
ascending series of ethanol solutions (70% to 100%) for 15
minutes each. Propylene oxide (Agar Scientific Ltd.) was used
as a transition solvent between ethanol and resin steps by
washing dehydrated samples twice in 100% propylene oxide
(15 min/wash), followed by incubation in a 1:1 mixture of
propylene oxide and resin for 1 hour. Six changes, approx-
imately 3 hours each, of Araldite resin (CY212 monomer; Taab
Laboratories, Aldermaston, United Kingdom) containing dode-
cenylsuccinic anhydride (DDSA) hardener (Agar Scientific Ltd.)
and benzyl di-methyl amine (BDMA) accelerator (Agar Scien-
tific Ltd.) ensured total removal of residual propylene oxide
and complete infiltration of resin into each specimen block.
Samples were then transferred to molds and polymerized for a
minimum of 24 hours at 608C. Ultrathin sections (~90 nm)
were created using a Leica UC6 ultramicrotome (Leica Micro-
systems (UK) Ltd., Milton Keynes, United Kingdom) equipped
with a diamond knife. Sections were collected on copper grids
(3.05 mm) and stained for 30 minutes with a saturated uranyl
acetate solution for added collagen contrast, followed by three
rinses in 0.2-lm filtered distilled water (5 min/rinse). Sections
were allowed to dry and examined using a JEOL 1010
transmission electron microscope (Jeol (UK) Ltd., Welwyn
Garden City, United Kingdom) operating at 80 kV.
Immunofluorescence
WT and null whole mouse eyes were harvested fresh,
embedded in OCT compound, frozen on dry ice, and stored
at808C. Whole-eye cryosections 10 lm thick were collected
on poly-lysine–coated glass slides (Fisher Scientific, Lough-
borough, United Kingdom), using a Bright OTF5000 cryostat
(Bright Instruments Ltd., Luton, United Kingdom). Sectioning
was performed along the eye globe’s sagittal plane, and
sections were only kept for analysis if the iris was disconnect-
ed, indicating corneal tissue was centrally located over the
pupil. To prevent nonspecific background labeling between
anti-mouse secondary antibody and IgG native to mouse
corneal tissue, primary and secondary antibodies were
incubated overnight at 48C with constant rotation in the
following reaction mixture: primary and secondary antibodies
were diluted 1:10 and 1:50, respectively, in 13 PBS with 0.1%
Tween-20 and 2% BSA (PBS-TþBSA).27,28 This preincubation
facilitated the interaction between secondary antibodies and
the Fc region of primary antibodies, minimizing erroneous
localization of secondary to murine corneal sections. For 30
minutes prior to tissue application, heat-deactivated normal
mouse serum was added to antibody and control mixtures at a
concentration of 5 lL/lg secondary antibody to bind
potentially free secondary antibody (further reducing back-
ground labeling). Rehydration of sections was achieved by
applying PBS-T for 5 minutes. Sections were immersed for 30
minutes in 1% Triton X-100 in PBS to further reduce
background fluorescence. Sections were briefly rinsed in
PBS-T prior to blocking or, in some cases, application of the
keratanase or chondroitinase ABC enzymes. When applied,
both keratanase and chondroitinase ABC were prepared at a
0.4 U/mL concentration in either 10 mM Tris-HCl (keratanase)
or 50 mM Tris and 60 mM sodium acetate with 0.02% BSA
(chondroitinase ABC); digestion occurred for 2 hours at 378C in
both cases. Sections were rinsed with PBS-T following enzyme
incubation (where applicable) and blocked for 30 minutes
with 10% (v/v) normal goat serum in PBS-TþBSA. Finally, tissue
sections were covered in a generous volume of the antibody
mixture for 4 hours at room temperature in a humid
atmosphere. Following application of primary-secondary com-
plexed antibody solutions, sections were thoroughly washed
with PBS-T and mounted with Vectashield dual mountant and
40,6-diamidino-2-phenylindole (DAPI) stain. Control solutions
were prepared as described above, except PBS-TþBSA buffer
replaced the volume of the primary antibody. Slides were
stored at 48C for no more than 24 hours before imaging as
described below. Images were collected with an Olympus
BX40 fluorescence microscope equipped with an SIS F-View
black and white digital camera (Olympus Keymed Ltd.,
Southend-on-Sea, United Kingdom). Olympus Cell^P imaging
software (Olympus Keymed Ltd., Southend-on-Sea, United
Kingdom) was used to capture images in TIFF format.
RESULTS
B3gnt7-Null Mouse Phenotype
Intercross of B3gnt7 heterozygotes produced WT, htz, and null
mice at normal Mendelian frequency. B3gnt7-null mice were
born without any detectable abnormalities and were indistin-
guishable from WT and B3gnt7-htz littermates during devel-
opment from neonate to adult stages, indicating neither
abnormalities nor major visible phenotypes arise from
B3gnt7-null mutation. A 1-year follow-up study showed that
B3gnt7-null mutations were nonlethal, and mice maintained
normal development, lacking any overt abnormalities. Inter-
cross of null mice produced litters of comparable size to those
of intercrossed WT mice, indicating that the mutant mice have
normal reproductive potential.
Corneal Thickness
Thickness measurements of the whole cornea, the collagen-
rich corneal stroma, and the corneal epithelium in WT, B3gnt7-
htz, and B3gnt7-null eyes were collected (Fig. 2). Dimensions
of the cornea were comparable in WT and htz tissue, with the
epithelium measuring 34 6 1 vs. 33 6 1 lm, the whole cornea
measuring 109 6 2 vs. 108 6 3 lm, and the stroma measuring
75 6 2 vs. 75 6 3 lm (all comparisons WT versus htz). None
of these small differences were statistically significant. Corneal
epithelial thickness in the B3gnt7-null mouse, at 32 6 1 lm,
also showed no statistical differences (P ¼ 0.4702 and P ¼
0.8898, respectively) to the epithelial thickness measurements
of the WTor htz corneas. In contrast, a noteworthy decrease in
corneal stromal thickness in B3gnt7-null mouse eyes, mea-
sured at 60 6 2 lm, was noted. This measurement was less
than the corresponding values for the WT and htz corneal
stromas (75 6 2 and 756 3 lm, respectively; P¼0.0024 and P
¼ 0.0002). Given that the epithelial thicknesses in each of the
three genotypes was unaltered, the reduction in stromal
thickness was reflected in the whole cornea thickness
measurements. The B3gnt7-null whole cornea was thinner
than WT and htz corneas (93 6 2 vs. 109 6 2 and 108 6 3 lm,
respectively: P ¼ 0.0011 and P ¼ 0.0002).
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KS Chain Length, Lumican Production, and
Galactose Sulfation
KS-chain length, lumican expression, and galactose sulfation
patterns in WT, htz, and null tissues were investigated using
extracted corneal protein for Western blot analyses. Three
samples were prepared for each genotype: untreated, PNGase
F digested, and endo-b-galactosidase digested. The untreated
samples, prepared to determine intact KS-GAG chain length as
a function of the rate at which lumican migrated through the
electrophoretic gel, revealed that WT and htz produced similar
high-to-low molecular weight smear patterns, ranging from
~160 to 45 kDa (Fig. 3, lanes 1 and 2, respectively). In
contrast, B3gnt7-null corneal extracts showed a more con-
densed band from ~65 to 45 kDa (Fig. 3, lane 3), suggesting
that lumican from B3gnt7-null extracts may be substituted
with lower-molecular-weight (i.e., shorter) KS-GAGs compared
with WT or htz samples. To confirm that this finding was a
consequence of KS-GAG chain length, PNGase F was used to
cleave KS side chains from their lumican core proteins. After
PNGase F predigestion, all three samples showed identical
narrow bands at ~40 kDa (Fig. 3, lanes 4–6), which
corresponds to the known molecular weight of lumican, ~36
to 40 kDa.29 Endo-b-galactosidase (endo-b-gal-ase) treatment
was used to probe for aberrant galactose sulfation of KS-GAGs,
as its cleavage site is the b-1,4 glycosidic linkage between
unsulfated galactose and GlcNAc (sulfated or unsulfated).30 It
should be noted that endo-b-gal-ase will cleave at each
unsulfated galactose along KS-GAGs, leaving lumican core
proteins bound to the KS linkage region and GAG stub
proximal to the innermost unsulfated galactose. Therefore,
because WT, htz, and null samples that were digested with this
enzyme produced bands of comparable molecular weight and
density at ~47 kDa (Fig. 3, lanes 7–9), it was inferred that the
innermost unsulfated galactose was not atypically oversulfated
in B3gnt7-htz and -null mutants. Whether or not galactose
residues in the non-reducing terminal region of KS are affected
by the B3gnt7 mutation remains unknown.
Electron Microscopy: Tissue Architecture
Corneal tissue was examined by electron microscopy at high
magnification such that aligned collagen fibrils were oriented
in longitudinal section. Visualization of polyanionic PG
structures was achieved via the inclusion of cupromeronic
blue in the primary fixative.25,31 Because cupromeronic blue
binds the two major families of PGs native to the corneal
stroma—CS/DS-PGs and KS-PGs—chondroitinase ABC was
required to distinguish CS/DS from KS in electron micrographs.
Tissue from all three groups was either left intact (Fig. 4, left
column) or subjected to chondroitinase ABC (Fig. 4, right
column), an enzyme that hydrolyzes glycosidic linkages within
the core structure of CS/DS-GAGs32,33 without affecting KS-
PGs. It should be noted that heparan sulfate, a third class of
PGs, is also present in corneal tissue, albeit at much lower
levels in the stroma than either KS- or CS/DS-PGs.34 Chon-
droitinase ABC preincubation was therefore sufficient for
distinction between the two major classes of stromal PGs.
Non–enzyme-treated WT corneas showed many electron
dense structures extending perpendicularly from collagen fibril
axes, which sometimes appeared to associate with collagen at
consistent distances (Fig. 4a, white asterisks). Occasionally,
longer filaments traversing through or aligning with collagen
fibrils were identifiable (Fig. 4a, black arrows). Very fine, short
strands of low contrast were also observed projecting outward
from collagen fibril axes (Fig. 4a, black arrowhead) throughout
the untreated WT stroma. Non–enzyme-treated B3gnt7-htz
tissue (Fig. 4c) presented phenotypically similar to the WT
tissue, with numerous electron dense structures associating
with collagen in parallel and perpendicular fashions (Fig. 4c,
FIGURE 2. Whole cornea, stromal, and epithelial thicknesses of WT, B3gnt7-htz, and null tissue. WT (black bars) and htz (dark gray bars)
measured similarly, with whole cornea thicknesses of 109 6 2 vs. 108 6 3 lm and stromal thicknesses of 75 6 2 vs. 75 6 3 lm. Stromal, and
therefore whole cornea, thickness of B3gnt7-null (light gray bars) tissue was significantly thinner than those of the WT and htz, measuring 60 6 2
and 93 6 2 lm, respectively. This result contrasted with epithelial thicknesses, where WT, htz, and null measured 34 6 1, 33 6 1, and 32 6 1 lm,
respectively.
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black arrows). Polyanionic structures observed in untreated
B3gnt7-null tissue appeared several-fold longer than those in
WT or htz samples and contained many filamentous offshoots
extending perpendicularly from their axes (Fig. 4e, white
arrowheads). Critical measurements for accurate comparison
of PG length were not possible without three-dimensional
imaging, owing to the tortuous course of these structures,
which ramified in and out of the plane of the ultrathin section.
Additionally, whereas most of the PGs found in WT specimens
in this study associated orthogonally to collagen fibrils, the
structures prevalent in the null specimen mainly aligned
parallel to fibril axes.
Compared with their untreated counterparts shown in the
left column of Figure 4, overall GAG content visibly decreased
in all specimens following chondroitinase ABC digestion (Fig.
4, right column). Black arrowheads in Figures 4b and 4d
identify residual short strands, thought to be KS-PGs owing to
their chondroitinase ABC resistance, found throughout the
stroma in WT and htz samples (Figs. 4b, 4d, black arrow-
heads).14,35 Interestingly, B3gnt7-null corneal specimens did
not feature polyanionic structures following chondroitinase
ABC digestion, suggesting an atypical absence of KS in
circumstances where both alleles of B3gnt7 were mutated.
Additionally, the irregular PGs found throughout the untreated
null sample were totally eliminated from the null corneal
stroma upon chondroitinse ABC preincubation, suggesting the
anomalous PGs were elongated electron-dense CS/DS-PG
filaments.
The cupromeronic blue-enhanced PG phenotypes dis-
cussed here were similar at anterior, middle, and posterior
stromal depths, as was collagen fibril diameter. No aberrantly
thick or thin collagen fibrils were observed in any of the
genotypes or stromal regions studied (data not shown). Finally,
corneal tissue that was incubated in buffer-maintained
morphology and proteoglycan content comparable to non–
enzyme-treated tissue, confirming that diminished PG content
was dependent on active chondroitinase enzyme.
Immunofluorescence: Confirming the KS and CS/
DS Phenotypes
The mouse monoclonal antibody 1B4, which is specific for low
sulfated KS,36 was applied to cryosections of WT and null
corneas to localize KS-GAGs. Traditionally, detection of highly
sulfated KS is achieved with 5D4, a mouse monoclonal
antibody with specificity for KS hexasaccharides with a
minimum of five sulfate moieties.37,38 However, previous work
has demonstrated the 5D4 epitope is not present in mouse
corneal tissue at a concentration sufficient for immunofluores-
cent labeling.35 As such, we instead probed samples with 1B4
to visualize low sulfated KS. Figure 5a shows the WT corneal
stroma was diffusely fluorescent when probed for sulfated KS-
GAGs. Additionally, brightly punctate fluorescence was dis-
cernible at various stromal depths (Fig. 5a, white arrows).
These results contrasted with null tissue, which showed only
faint epithelial staining juxtaposed to a dark stroma (Fig. 5e).
FIGURE 3. Electrophoretically separated untreated (lanes 1–3), PNGase F– (lanes 4–6), and Endo-b-Gal-ase–digested (lanes 7–9) corneal extracts
were probed for the KS core protein, lumican. Untreated WT and htz samples produced smear patterns from ~160 to 45 kDa (lanes 1, 2), whereas
untreated null extracts showed a more condensed band from 45 to 65 kDa (lane 3). PNGase F cleaved KS-GAG chains from lumican core proteins in
lanes 4–6. The migration of lumican into narrow, low-molecular-weight bands at 40 kDa for all three samples indicated the differential smear
patterns in the untreated samples were a result of altered KS structures. Lanes 7–9 show lumican localization following cleavage of KS-GAGs at
unsulfated Gal residues using Endo-b-Gal-ase. All three samples showed thick bands at ~46 kDa following this treatment, suggesting sulfation of Gal
residues is unaffected by the B3gnt7 mutation.
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Figures 5b and 5d represent tissue sections that were subjected
to keratanase digestion before immuno-labeling for KS. Because
stromal fluorescence in the WT was abolished following
keratanase predigestion, it was inferred that the signal
observed in the undigested WT tissue was indeed due to
specific labeling of KS-GAGs.
Immunofluorescence was also used to detect possible
changes in CS/DS content of the null corneal stroma compared
with WT tissue. To this end, 2B6 antibody, which requires
chondroitinase ABC predigestion to reveal the chondroitin-4-
sulfate and DS epitopes,36,39,40 was applied to corneal sections.
Both WT (Fig. 5c) and null (Fig. 5g) specimens produced
fluorescent signal through the depth of the cornea. The null
specimen displayed slightly stronger signal compared with the
WT, perhaps reflecting the appearance of the distinctively
elongated family of electron dense PG filaments observed in
FIGURE 4. Electron micrographs of untreated (a, c, e) and chondroitinase ABC-digested (b, d, f) WT, htz, and null corneal stromal tissue. All images
show striated collagen fibrils running in longitudinal section. Putative CS/DS-PGs (black arrows, a, c) were observed throughout the stroma of
untreated WT (a) and htz (c) corneal tissue and sometimes associated with collagen fibrils at regular intervals (white asterisks, a). KS-PGs appeared
shorter and projected outward to the next nearest collagen fibril in untreated WT tissue (black arrowhead, a). Untreated null specimens (e)
possessed markedly elongated, branched PG filaments (white arrows) that were not seen in WT or htz samples. In all three groups, overall PG
content decreased on chondroitinase ABC preincubation, although only the WT and htz (b, d, respectively) specimens contained residual short
chain KS-PGs (black arrowheads). The lack of any discernible PGs following enzymatic digestion in the null (f) samples suggested an abnormal KS-
PG phenotype, arising from defunct b3GnT7. All images were taken at 20,0003magnification. Scale bar denotes 100 nm.
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electron micrographs. The 2B6 antibody was also applied to
sections without revealing the epitope via chondroitinase ABC
predigestion as a form of negative control. As expected, neither
WT nor null (Figs. 5d, 5h, respectively) corneas exhibited
positive fluorescence under these conditions.
DISCUSSION
The work presented here revealed for the first time a
relationship between b3GnT7 and the KS-PG phenotype in
murine corneal tissue. Our findings, discussed below, demon-
strated that an abnormally attenuated B3gnt7-null mouse
corneal stroma lacked histochemically detectable KS-PGs.
The concurrent appearance of elongated, branched electron
dense PG filaments in this knockout mouse, which were
susceptible to chondroitinase ABC, perhaps preserved corneal
ultrastructure in absence of typical KS-PGs.
Because in vitro work by Kitayama et al.17 identified
b3GnT7 as a key enzyme in KS-GAG elongation, we
hypothesized that KS-PGs would be altered in the B3gnt7-null
tissue, thereby affecting overall corneal architecture. Lumican
from B3gnt7-null corneas appeared to be modified with
shorter carbohydrate chains than those from WT and B3gnt7-
htz corneas (Fig. 3), indicating that b3GnT7 is a major enzyme
contributing to corneal KS-GAG synthesis. This is consistent
with previously published in vitro observations. Endo-b-gal-ase
digestion shortened carbohydrate chains on lumican protein
cores in WT, B3gnt7-htz, and null corneas, the resulting
structures of which appeared to contain short remnants of
either poly-N-acetyllactosamine or KS-GAGs. There are eight
b1,3-GlcNAc transferases in mice, and both b-1,3-N-acetylglu-
cosaminyltransferase-2 (b3GnT2) and b3GnT7 have been
shown to act on KS-GAG synthesis in vitro.17,18 Thus, it is
possible that b3GnT2 may work on KS-GAG chain production
to compensate for lack of b3GnT7 in B3gnt7-null corneas.
Although, if b3GnT2 participates in KS biosynthesis, its action
is apparently insufficient to fully elongate KS-GAGs in absence
of b3GnT7. Future studies should determine whether these
results are reflected in all KS-PG core proteins, including
keratocan and mimecan, because we analyzed lumican KS-PGs
as a representative carrier of KS-GAGs in the mouse cornea.
We believe the widespread disappearance of KS-PGs from
EM and fluorescence images of the affected null corneas, but
not in the WT, supports the idea that the biosynthetic
mechanism underlying KS-PG synthesis was disrupted in cases
where both alleles of B3gnt7 were deactivated (Fig. 6). These
results confirmed predictions of in vitro work, despite the
biosynthesis environment in vivo differing. Whereas in vitro
studies were conducted with solubilized enzymes and synthet-
ic oligosaccharide constructs,18 in vivo glycosyltransferases
and sulfotransferases are membrane-bound enzymes within
Golgi compartments. Indeed, it is as yet unconfirmed whether
or not these glycosyl- and sulfotransferases share Golgi
compartments in keratocytes, allowing them to act in tandem
as hypothesized. That said, highly sulfated KS was detected in
culture media of human corneal epithelial cells that were
modified to express both CGn6ST and KSGal6ST, perhaps
complementing their endogenously expressed b3GnT7 and
b4GalT4.17 The consistent importance of b3GnT7 in in vitro,
and now in our in vivo, assays provides strong evidence for the
participation of b3GnT7 in corneal KS-GAG synthesis.
Architecture of the B3gnt7-null mouse cornea emulates
stromal changes characteristic of human macular corneal
dystrophy (MCD) and Chst5-null mouse tissue, both of which
lack properly sulfated KS throughout the corneal matrix.
Corneal phenotypes in both human MCD and murine Chst5-
null present with a ~20% reduced stromal thickness,14,41 an
FIGURE 5. Immunofluorescent labeling of low-sulfated KS- and CS/DS-GAGs in WT (a–d) and null (e–h) corneal tissue. WT tissue labeled for KS-
GAGs fluoresced at all stromal depths and featured occasional bright punctae (white arrows, a); this signal was sensitive to keratanase (KSase)
digestion (b). The lack of fluorescent signal in the null corneal stroma, without (e) or with (f) KSase incubation, implied a lack of sulfated KS-GAGs
in the mutated corneal stroma. Chondroitinase ABC-liberated CS/DS-GAG ‘‘stubs’’ were local to WT (c) and null (g) tissue throughout the depth of
the corneal stroma. A brighter stromal fluorescent signal from the null specimen, relative to the WT control, indicated increased CS/DS content in
the B3gnt7 knockout. In absence of chondroitinase ABC predigestion, neither WT (d) nor null (h) tissue appeared positive for the 2B6 stub epitope.
Epi, corneal epithelium; st, stroma. All images were collected at 403magnification. Scale bar denotes 50 lm.
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attenuation equivalent to the amount of stromal thinning
observed in the B3gnt7-null specimen in our corneal thickness
assay (Fig. 2). Interestingly, human CHST6 and murine Chst5
mutations result in deactivation of human CGn6ST and the
analogous mouse intestinal GlcNAc-6-O-sulfotransferase, re-
spectively, without which the KS-GAG biosynthetic pathway
cannot proceed. Because all three of these cases—B3gnt7-null,
MCD, and Chst5-null—result in abnormally short KS-GAG
chains and experience similar levels of stromal thinning, we
propose that this consistent phenotype results from decreased
water retention within the stroma, arising from a deficiency in
water sorptive KS-PGs.42,43 The ultrastructural basis for the
thin cornea in MCD is believed to be a closer-than-normal
packing of the uniformly thin collagen fibrils, which make up
the bulk of the corneal stroma.9 This is thought to arise from a
reduction in water-binding potential in the extrafibrillar space,
alluded to above, augmented by a lack of mutual repulsion
between charged KS side chains on KS-PGs, whose protein
cores are bound to collagen fibrils. Indeed, this concept finds
some support in depth-profiled studies of collagen fibril
spacing in human MCD corneas, which show that the
compaction of collagen fibrils is more prevalent in the
posterior corneal stroma,9,44 a region of the tissue in
mammalian corneas in which KS-GAGs are most abundant.45–47
Reduction in center-to-center distance between collagen fibrils
was observed in x-ray diffraction studies of Chst5-null corneal
tissue,14 further demonstrating a role for KS-PGs in mainte-
nance of interfibrillar spacing. The relatively thin corneal
stroma of the B3gnt7-null specimen perhaps arises from a
comparable change in collagen packing, although this hypoth-
esis should be demonstrated empirically in future publications.
In addition to the anomalous KS-PG phenotype discovered
in the B3gnt7-null cornea, a concomitant appearance of
uniquely elongated, branched electron dense PG filaments
was found when corneas were examined using electron
microscopy. The susceptibility of these PGs to chondroitinase
ABC digestion indicates the atypical PGs were CS/DS in nature.
Similar CS/DS structures were previously observed by electron
microscopy in Chst5-null corneas of mice lacking keratan
sulfate sulfotransferase.15 Lateral aggregation or end-to-end
aggregation of single GAGs were suggested as possible
mechanisms generating these supernormal structures, and
we speculate that similar processes may underlie their
appearance in B3gnt7 mutants as well. However, future work
is required on this knockout to reveal the nature of the highly
electron dense structures revealed by electron microscopy.
That said, an argument for upregulation of CS/DS-PGs in
absence of KS-PGs could be rationalized. Considering that
corneal transparency partially relies on repulsion between
negatively charged KS- and CS/DS-PGs,48 it is unsurprising that
upregulation of CS/DS-PGs may prevent the breakdown of
collagen organization necessary for corneal clarity in the event
of a charge deficit (i.e., in the absence of elongated, sulfated
KS). Indeed, this compensation mechanism was posited before
by Hayashida et al.,14 whose work revealed Chst5-null mice
formed ‘‘caterpillar-like’’ structures susceptible to chondroiti-
nase ABC digestion, similar—if not, identical—to those
described in this study. The possibility of a compensatory
mechanism is further supported by the work of Plaas et al.,49,50
which characterized the GAG content of normal human
corneas versus those affected by MCD. Their work demon-
strated that diseased tissue contained fewer sulfated KS-PGs,
and CS/DS-PGs were significantly increased and were in an
atypically oversulfated form.
The data within demonstrate that the GlcNAc-transferring
ability of b3GnT7 is necessary for synthesis of corneal KS-GAGs
and aid our understanding of the structure–function relation-
ship between KS and corneal ultrastructural organization.
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